Meeting
2012 ASCO Annual Meeting
DJ-1 as a predictor of pathologic complete remission of neoadjuvant chemotherapy with breast cancer patients.
Authors
Takahiko Kawate
Basic Pathology, National Defence Medical Colleage, Saitama-ken, Japan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 30, 2012 (suppl; abstr 10544)
DOI
10.1200/jco.2012.30.15_suppl.10544
Abstract #
10544
Poster Bd #
43A
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Sperm associated antigen 5 (SPAG5) as a predictor and monitor for response and distant relapse risk (DRR) to endocrine (ET) and chemo-therapies (CT) in oestrogen receptor positive (ER+) breast cancer (BC).
First Author: Tarek Mohamed Ahmed Abdel-Fatah
Poster
2014 ASCO Annual Meeting
Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
First Author: Peter D. Beitsch
Poster
2012 Breast Cancer Symposium
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: Results of a multivariate analysis.
First Author: Christiane Matuschek
Poster
2012 ASCO Annual Meeting
Role of proliferation in response to neoadjuvant chemotherapy in GEICAM/2006-03 and GEICAM/2006-14 breast cancer patients.
First Author: E. Alba